Mary Thistle

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Mary Thistle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Thistle:

Form 4 holding Director

Q32 Bio Inc.

Security class
Stock Option (Right to Buy)
Shares / value
53,521
Estimated value
$171,333
Report date
23 Oct 2025
Price
$13.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Vigil Neuroscience, Inc.

Security class
Stock Option Award (Right to Buy)
Shares / value
0
Estimated value
$137,642
Report date
05 Aug 2025
Price
$7.62
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Alaunos Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
100,000
Estimated value
Report date
06 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cullinan Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,743
Estimated value
Report date
08 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Mary Thistle

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .